Searchable abstracts of presentations at key conferences in endocrinology

ea0067o67 | Oral Presentations | EYES2019

Treatment intensification with novel antidiabetic agents alters platelet function parameters in patients with type 2 diabetes

Bletsa Evanthia , Siasos Gerasimos , Stampouloglou Panagiota K , Paschou Stavroula A , Antonopoulos Alexios , Batzias Konstantinos , Gouliopoulos Nikolaos , Zaromytidou Marina , Oikonomou Evangelos , Tsigkou Vasiliki , Mourouzis Konstantinos , Pavlou Efthimia , Kozanitou Maria , Thanopoulou Anastasia , Vryonidou Andromachi , Kassi Eva , Tentolouris Nikolaos , Pallantza Zoi , Tousoulis Dimitris

Background: Patients with type 2 diabetes (T2D) are at higher risk for thrombotic events and as a result cardiovascular disease. Platelet function may be used to assess prothrombotic state in patients with cardiovascular disease.Purpose: We aimed to investigate whether the administration of novel antidiabetic agents influence platelet function in TDM2 patients.Patients and Methods: We 60 enrolled consecutive patients with T2DM, on ...